Skip to main content
Clinical Trials/EUCTR2020-001054-22-DK
EUCTR2020-001054-22-DKActive, not recruitingPhase 1

aparoscopic vs Ultrasound-Guided Transversus Abdominis Plane Block in Minimally Invasive Colon Surgery: A Randomized Controlled Multicentre Clinical Trial - OPMICS

Claus Anders Bertelsen0 sites360 target enrollmentStarted: March 25, 2020Last updated:
Drugs

Trial Snapshot

Phase
Phase 1
Status
Active, not recruiting
Sponsor
Enrollment
360

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
All

Inclusion Criteria

  • -Patients planned to receive curative elective minimally invasive colon surgery for colon cancer or adenoma without a planned ostomy. Colon cancer or adenoma is defined by a distance of more than 15 cm from the anal verge to the distal limitation of the tumour or adenoma as measured by rigid sigmoidoscope.
  • -Age = 18 years
  • -Having given informed written consent.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 150
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 210

Exclusion Criteria

  • -Known allergy to local analgesics
  • -Known liver failure Class C according to the Child-Pugh Score
  • -Body weight of less than 40 kg
  • -History of being a chronic pain patient (weekly intake WHO step II or step III or adjuvant step I analgesic)19
  • -Presence of concomitant painful conditions other than low back pain that could confound the subject's trial assessments or self-evaluation of the index pain, e.g., syndromes with widespread pain such as fibromyalgia
  • -Predictably non-compliant due to language barrier or psychiatric disease
  • -Patients rescheduled for open surgery, before the intervention has been administered
  • -Patients where the indication for surgery changes before the intervention has been administered
  • -Patients with known inflammatory bowel disease
  • -Patients who have previously undergone open major abdominal surgery defined by prior intraabdominal surgery with a midline or upper abdominal incision of more than 8 cm
  • -Incisional hernia
  • -Patients with a history of abdominal wall surgery including resection of the external oblique muscles, the internal oblique muscles, the transversus abdominis muscles, the rectus abdominis muscles or their fascial components
  • -Pregnancy.

Investigators

Sponsor
Claus Anders Bertelsen

Similar Trials